Despite being only 35, Michal Šimíček heads the Blood Cancer Research Group in Ostrava, a team doing very exciting work in the field of cell therapy. This ground-breaking treatment involves using live immune system cells to target certain kinds of tumors and Šimíček’s aim is to create universal cells that could be taken from any donor, so making the treatment way more affordable than it is now.